Search Results - "Paudel, B Bishal"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
  2. 2

    Nucleocytoplasmic transport of active HER2 causes fractional escape from the DCIS-like state by Wang, Lixin, Paudel, B. Bishal, McKnight, R. Anthony, Janes, Kevin A.

    Published in Nature communications (13-04-2023)
    “…Activation of HER2/ErbB2 coincides with escape from ductal carcinoma in situ (DCIS) premalignancy and disrupts 3D organization of cultured breast-epithelial…”
    Get full text
    Journal Article
  3. 3

    An unbiased metric of antiproliferative drug effect in vitro by Harris, Leonard A, Frick, Peter L, Garbett, Shawn P, Hardeman, Keisha N, Paudel, B Bishal, Lopez, Carlos F, Quaranta, Vito, Tyson, Darren R

    Published in Nature methods (01-06-2016)
    “…Conventional metrics for assessing antiproliferative drug effect have time-dependent biases that may skew results. The drug-induced proliferation rate can be…”
    Get full text
    Journal Article
  4. 4

    Proteome-wide copy-number estimation from transcriptomics by Sweatt, Andrew J, Griffiths, Cameron D, Groves, Sarah M, Paudel, B Bishal, Wang, Lixin, Kashatus, David F, Janes, Kevin A

    Published in Molecular systems biology (27-09-2024)
    “…Protein copy numbers constrain systems-level properties of regulatory networks, but proportional proteomic data remain scarce compared to RNA-seq. We related…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype by Jia, Dongya, Paudel, B. Bishal, Hayford, Corey E., Hardeman, Keisha N., Levine, Herbert, Onuchic, José N., Quaranta, Vito

    Published in Frontiers in oncology (14-08-2020)
    “…Cancer cells adjust their metabolic profiles to evade treatment. Metabolic adaptation is complex and hence better understood by an integrated…”
    Get full text
    Journal Article
  7. 7

    Dynamics of drug response informs rational combination regimens by Paudel, B Bishal, Quaranta, Vito

    Published in Science signaling (20-08-2019)
    “…Metabolic plasticity in cancer has been linked to the development of drug-tolerant populations. In this issue of , Goldman integrate metabolic plasticity with…”
    Get more information
    Journal Article
  8. 8

    Quantifying Drug Combination Synergy along Potency and Efficacy Axes by Meyer, Christian T, Wooten, David J, Paudel, B Bishal, Bauer, Joshua, Hardeman, Keisha N, Westover, David, Lovly, Christine M, Harris, Leonard A, Tyson, Darren R, Quaranta, Vito

    Published in Cell systems (27-02-2019)
    “…Two goals motivate treating diseases with drug combinations: reduce off-target toxicity by minimizing doses (synergistic potency) and improve outcomes by…”
    Get more information
    Journal Article
  9. 9

    A Nonquiescent “Idling” Population State in Drug-Treated, BRAF-Mutated Melanoma by Paudel, B. Bishal, Harris, Leonard A., Hardeman, Keisha N., Abugable, Arwa A., Hayford, Corey E., Tyson, Darren R., Quaranta, Vito

    Published in Biophysical journal (27-03-2018)
    “…Targeted therapy is an effective standard of care in BRAF-mutated malignant melanoma. However, the duration of tumor remission varies unpredictably among…”
    Get full text
    Journal Article
  10. 10

    Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition by Hardeman, Keisha N., Peng, Chengwei, Paudel, Bishal B., Meyer, Christian T., Luong, Thong, Tyson, Darren R., Young, Jamey D., Quaranta, Vito, Fessel, Joshua P.

    Published in Scientific reports (16-02-2017)
    “…Dysregulated metabolism can broadly affect therapy resistance by influencing compensatory signaling and expanding proliferation. Given many BRAF-mutated…”
    Get full text
    Journal Article
  11. 11

    Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation by Frick, Peter L., Paudel, Bishal B., Tyson, Darren R., Quaranta, Vito

    Published in Journal of cellular physiology (01-07-2015)
    “…The dynamics of heterogeneous clonal lineages within a cell population, in aggregate, shape both normal and pathological biological processes. Studies of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Abstract 670: Molecular basis of the idling state uncovers vulnerabilities suitable to sequential targeting in melanoma by Hayford, Corey E., Paudel, Bishal B., Harris, Leonard A., Hardeman, Keisha N., Tyson, Darren R., Quaranta, Vito

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Recent published work from the lab identified a novel “idling” population state in the response of BRAF-mutant melanoma cancer cell lines to BRAF…”
    Get full text
    Journal Article
  14. 14

    Abstract 2894: Overcoming intrinsic resistance to BRAF -inhibitors by modulating redox balance in BRAF -mutated melanoma cells by Paudel, B. Bishal, Harris, Leonard A., Hardeman, Keisha N., Hayford, Corey E., Meyer, Christian T., Abugable, Arwa A., Tyson, Darren R., Fessel, Joshua P., Quaranta, Vito

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Post-resistant tumor analyses or static measurements provide most of our current knowledge of tumor recurrence. Unfortunately, these studies neither…”
    Get full text
    Journal Article
  15. 15

    Abstract 4947: Uncovering the molecular basis for clinically relevant sphingolipidomic subtypes in acute myeloid leukemia by Paudel, B Bishal, Tan, Su-Fern, Ung, Johnson, Claxton, David, Feith, David J., Loughran, Thomas P., Janes, Kevin A.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Abstract Acute myeloid leukemia (AML) has been extensively studied at the genomic level, resulting in various genomic classifications. Despite the progress,…”
    Get full text
    Journal Article
  16. 16

    An unbiased metric of antiproliferative drug effect in vitro by Harris, Leonard A, Frick, Peter L, Garbett, Shawn P, Hardeman, Keisha N, Paudel, B. Bishal, Lopez, Carlos F, Quaranta, Vito, Tyson, Darren R

    Published 22-05-2016
    “…Nature Methods 13, 497-500 (2016) In vitro cell proliferation assays are widely used in pharmacology, molecular biology, and drug discovery. Using theoretical…”
    Get full text
    Journal Article
  17. 17
  18. 18